2020 Half Year Media Release
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- 2019 AGM CEOs Speech
- E4/DRSP contraceptive presented at EU gynecology conference
- MYX signs license agreement for novel oral contraceptive
- 2019 Full Year Results Investor Presentation
- 2019 Full Year Results Media Release
Later from Mayne Pharma
- 2020 Half Year Investor Presentation
- Mayne Pharma submits NDA for E4/DRSP to the FDA
- MYX signs license agreement for contraceptive in Australia
- S&P DJI Announces June 2020 Quarterly Rebalance
- MYX announces FDA filing acceptance of E4/DRSP in the US
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma